
04
2023
-
01
Commonly Used Cardiovascular Drugs: General Knowledge of Drug Use and Frequently Asked Questions
First-line antihypertensive agents include five major classes: calcium antagonists (CCBs), angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor antagonists (ARBs), beta-blockers (BBs), and diuretics.
First-line antihypertensive drugs include five major classes: calcium antagonists (CCBs), angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor antagonists (ARBs), beta-blockers (BBs) and diuretics.
Calcium antagonists are mainly of the "diphenhydramine" class, which are dihydropyridine calcium antagonists, and there are also non-dihydropyridines such as verapamil and diltiazem. In the case of amlodipine, for example, it does not matter much which brand name is used, as long as the blood pressure is under control. Even if there is no amlodipine, there are similar drugs such as nifedipine, lacidipine, felodipine, benidipine, nifedipine, and so on.
Many patients suffering from hypertension who have been taking medication for a long time, often because a certain drug, a certain brand or a certain manufacturer's drug is no longer available, from the community hospitals to the general hospitals, or from one hospital to another, have to prescribe the one he is taking, which is completely unnecessary.
Simply in terms of lowering the magnitude or effect of antihypertensive drugs, antihypertensive drugs can not say which good how much, most hypertensive patients with good, with the right, suitable for their own on the good.
If you suffer from chronic kidney disease, the presence of proteinuria, diabetes and metabolic syndrome (such as obesity, etc.), patients with chronic heart failure and secondary prevention of coronary heart disease, you should choose angiotensin-converting enzyme inhibitors, a variety of "Puli", such as captopril belongs to this category, or choose the angiotensin receptor antagonists, a variety of "Sartan" such as valsartan belongs to this category.
Recommended News
2022-11-03